60 Degrees Pharmaceuticals Shares Slide After GoodRx Deal to Offer Discounts on ARAKODA
60 Degrees Pharmaceuticals said it has partnered with GoodRx to provide eligible consumers savings of up to 30% on ARAKODA (tafenoquine), the only FDA-approved once-weekly malaria prevention drug on the U.S. market, beginning February 2, 2026. The announcement preceded a 16.9% drop in the company's stock in premarket trading. The program will expan…